top of page


April 27th, 2022

AcureX Therapeutics is awarded a new grant from The Michael J. Fox Foundation to accelerate development of it's Parkinson's disease biomarker for drug development and clinical trials

November 9th, 2021

AcureX Therapeutics to present at the Michael J. Fox Foundation Webinar - Innovating from Drug Discovery through the Clinic: Novel Approaches to PD Therapeutic Development on November 10th, 2021

October 12th, 2021

AcureX Therapeutics is awarded a SBIR grant from the National Institute on Aging, part of the National Institutes of Health 

October 11th, 2021

AcureX Therapeutics to present at Oppenheimer - Biotech Emerging Science Summit

October 1st, 2021

AcureX Therapeutics is featured by the Stanford SPARK Program

September 9th, 2021

AcureX Therapeutics' inventor/co-founder and AcureX scientist publish a ground-breaking discovery in Nature Metabolism, accompanied by an associated editorial

August 31st, 2021

AcureX Therapeutics receives grant funding from The Silverstein Foundation for Parkinson's with GBA

bottom of page